1. PLIVA, a Member of the Teva Group Tihomir Oreskovic
President of the Management Board, Pliva Croatia Ltd.
October, 2013
Croatia & SEE

2. About TEVA – Strong Foundations
111 years in
existence
$20.3B 2012 revenues
$ EPS 73
manufacturing sites
Over 46,000 employees
60 countries
70B tablets and capsules per annum
55,000+ SKUs
1,000 molecules
Croatia & SEE 2

3. Core Strenghts Leading healthcare provider Balanced business model
Manufacturing strengths
Integrated
R&D
Entrepreneurial employees and culture
Partnering experience
Go-to-market capabilities 3
Croatia & SEE 3

4. PLIVA in Croatia – Pharma Leader in SEE
PLIVA, a member of the Teva Group (since 2008).
Established in 1921
The largest pharmaceutical company in Croatia and one of the leading pharma companies in SEE
generics
inovative products and therapies (Copaxone...)
regional partnerships
One of major exporters in Croatia
>80% for export (30% Russia; 25% USA)
2000 employees in Croatia
Croatia & SEE 4 4

5. Working from Croatia RUSSIA CANADA ASIA EU USA JAPAN LATAM SAR
Over 60 locations worldwide
Croatia & SEE

6. Croatia - Strategically Important Production Site for TEVA
New investment cycle in production
Teva is investing $200M+ in Croatia (2011 – 2014)
Significant expansion of production capacities in Zagreb
Construction of a new manufacturing plant and supporting facilities in Savski Marof
Vertically integrated production
highly sophisticated products
FDA approved
- regularly audited by the FDA (since 1965), EMEA and other
Higly qualified employees
Knowledge and best practice sharing
Croatia & SEE

7. Operations Croatia
Complying with the highest global quality standards Markets: US, EMIA, EU; >80% for export (30% Russia; 25% USA)
$100M+ construction of Sterile and Oral Solid Forms facilities
Technology driven manufacturing site
Significantly increased production capacities
80% for exports
Capacity 10B tabs
Croatia & SEE 7

8. TAPI Croatia - World’s Largest AZI Supplier
Chemical development center (98% for exports)
Markets: US, EMIA, EU, JP, CA, LATAM
$100M+ the construction of the state-of-the-art facilities
Investment in integrated environmental protection ($20M)
Supplying 90 % of AZI demand on regulated markets
100 % increase in production capacities
Croatia & SEE

9. PLIVA’s R&D Center of Excellence
R&D Croatia - holder of Teva's strategy for the development of complex products and NTEs
200+ highly skilled employees in R&D
Experience and knowledge in development of complex projects
Understanding of regulatory requirements: EU, US, CAN, EMIA, ASIA...
One of the biggest users of the R&D tax incentives in Croatia
Croatia & SEE

10. Beyond Production and R&D
SSC Zagreb
IT SSC
Finance SSC
Pharmakovigilance
Communications
Procuirment
development
Business
Regulatory
Quality
Legal HR
Regional &
Global support
Providing services to different sites/countries in EU, EMIA, Asia, Americas
Croatia & SEE

11. Working with Croatian Companies – Capabilities, Potentials and Opportunities
located in the heart of Central Europe
the leading market for SEE region,
highly skilled and educated people
average salaries below the EU average
EU member July 2013
Competitive incentives, R&D, employment capital
Croatia & SEE

12. Thank you!